tiprankstipranks
Trending News
More News >
Xspray Pharma AB (DE:6XP)
FRANKFURT:6XP
Germany Market

Xspray Pharma AB (6XP) Income Statement

Compare
2 Followers

Xspray Pharma AB Income Statement

Last quarter (Q4 2025), Xspray Pharma AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, Xspray Pharma AB's net income was kr-36.99M. See Xspray Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr -5.58Mkr -8.55Mkr -9.19Mkr -9.53Mkr -8.87M
Operating Expenses
kr 156.27Mkr 287.04Mkr 181.73Mkr 131.38Mkr 96.95M
Depreciation and Amortization
kr 5.58Mkr 5.48Mkr 9.19Mkr 9.53Mkr 8.87M
EBITDA
kr -156.27Mkr -277.76Mkr -169.81Mkr -122.13Mkr -87.82M
Operating Income
kr -161.85Mkr -283.24Mkr -181.73Mkr -133.07Mkr -97.95M
Other Income/Expenses
kr -9.69Mkr -2.44Mkr 2.05Mkr 1.40Mkr 1.25M
Pretax Income
kr -171.55Mkr -285.67Mkr -179.68Mkr -131.67Mkr -96.70M
Net Income
kr -171.44Mkr -285.52Mkr -179.67Mkr -130.27Mkr -96.70M
Per Share Metrics
Basic EPS
kr -4.46kr -8.62kr -6.76kr -6.13kr -4.98
Diluted EPS
kr -4.46kr -8.62kr -6.76kr -6.13kr -4.98
Weighted Average Shares Outstanding
38.45M 33.12M 26.58M 21.26M 19.41M
Weighted Average Shares Outstanding (Diluted)
38.45M 33.14M 26.59M 21.26M 19.41M
Currency in SEK

Xspray Pharma AB Earnings and Revenue History